An experimental study on the therapy of infantile hemangioma with recombinant interferon γ
An experimental study on the therapy of infantile hemangioma with recombinant interferon γ
复制标题
DOI:
10.1016/j.jpedsurg.2010.09.056
复制
发表时间:
2011-03-01
影响因子:
2.4
通讯作者:
Ji, Yi
中科院分区:
文献类型:
--
作者:
Peng, Qiang;Liu, Wenying;Ji, Yi
Background/Purpose: The purpose of this investigation was to study the effect of interferon gamma (IFN-gamma) in the treatment of infantile hemangioma.Methods: Hemangioma tissue excised from a 4-month-old female infant who underwent surgery were separated into small nubs (4 x 4 x 5mm(3)) and implanted subcutaneously into nude mice (2 nubs per mouse). Thirty-two surviving hemangioma nubs were randomly divided into 2 groups, an IFN-gamma-administered group (16) and a control group (16). Interferon gamma or saline solution was injected subcutaneously, and the growth of hemangioma in the nude mice was monitored. Proliferation and apoptosis of hemangioma were tested by immunohistochemistry and real-time polymerase chain reaction.Results: Seven days after IFN-gamma injection, the hemangiomas in the IFN-gamma-administered group were significantly smaller than that in the control group (P < .01). The proliferation cytokine Ki-67 mRNA in the IFN-gamma group was significantly lower than that in the control group (P < .05). DAPK-1 mRNA in the IFN-gamma group was significantly higher than that in the control group (P < .05). Cell apoptosis expression in the IFN-gamma group was significantly more than that in controls (P < .05).Conclusions: Exogenous IFN-gamma can treat hemangioma effectively in a nude mice model. Its mechanism was closely related to both inhibition of hemangioma proliferation and acceleration of its apoptosis. (C) 2011 Elsevier Inc. All rights reserved.